Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2023-09-15
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity and Cardiorespiratory Fitness in Adolescents With Autism Spectrum Disorder
NCT04950517
Somatic Diseases in Autistic Children
NCT05077020
Clinical and Neurophysiological Evolutions Through a Functional Rehabilitation of Social Communication in ASD
NCT02444117
Magnetic Resonance Imaging in Children and Adolescents With Autism and Multiple Complex Developmental Disorders
NCT00161135
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
NCT02154828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To collect a wide range of data in order to improve knowledge of children with autism spectrum disorder (ASD) in French-speaking Belgium by prospectively including all children and adolescents making a request to the centres of reference. The creation of a common database will make it possible to collect general socio-demographic, geographical and epidemiological data, to characterise the different profiles and to accurately monitor developmental trajectories.
* Evaluate the feasibility and practical implementation of the treatment proposed following a diagnosis of ASD in a child.
* Implement protocols to improve the quality of care for beneficiaries.
* To enable the development of fundamental research protocols. Many questions remain unanswered about the genetic, neuro-cognitive and linguistic characteristics of autism. Only rigorous studies carried out on large, carefully defined samples can advance research.
* Increase public knowledge and understanding of the ASD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ASD group
child/adolescent (under 18 years of age) applying to an autism reference center or being followed up in an autism reference center
inclusion in the register
socio-demographic data collection and proposed therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inclusion in the register
socio-demographic data collection and proposed therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université Libre de Bruxelles
OTHER
Université de Namur
UNKNOWN
University of Mons
OTHER
Université de Liège
OTHER
Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marine Houssa, PhD
Role: STUDY_CHAIR
Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLouvain
Brussels, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAP48 - TSA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.